| CYHB2401686 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-10-22 | | Jiangsu Hansoh Pharmaceutical Group Co Ltd | | | view |
| CYHB2401687 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-10-22 | | Jiangsu Hansoh Pharmaceutical Group Co Ltd | | | view |
| CYHS2101337 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2021-06-25 | | Jiangsu Hansoh Pharmaceutical Group Co Ltd;Changzhou Humon Pharmaceutical Co Ltd | | | view |
| CYHS2101338 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2021-06-25 | | Jiangsu Hansoh Pharmaceutical Group Co Ltd;Changzhou Humon Pharmaceutical Co Ltd | | | view |
| CYHS2301457 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2023-05-30 | | Hangzhou Zhuyangxin Pharmaceutical Co Ltd | | | view |
| CYHS2301458 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2023-05-30 | | Hangzhou Zhuyangxin Pharmaceutical Co Ltd | | | view |
| CYHS2301459 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2023-05-30 | | Hangzhou Zhuyangxin Pharmaceutical Co Ltd | | | view |
| CYHS2400955 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2024-03-29 | | Chongqing Shenghuaxi Pharmaceutical Ltd | | | view |
| CYHS2400957 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2024-03-29 | | Chongqing Shenghuaxi Pharmaceutical Ltd | | | view |
| CYHS2403524 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(4) | Generic Drug | 2024-10-18 | | Hunan Fangsheng Pharmaceutical Co Ltd | | | view |
| JXHB2100013 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-01-23 | Actelion Pharmaceuticals Ltd | Actelion Pharmaceuticals Ltd;Excella GmbH | In Review | 2021-01-22 | view |
| JXHB2100019 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-02-05 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Excella GmbH;Actelion Pharmaceuticals Ltd | In Review | 2021-02-05 | view |
| JXHB2100020 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-02-05 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Excella GmbH;Actelion Pharmaceuticals Ltd | In Review | 2021-02-05 | view |
| JXHB2200143 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-09-19 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
| JXHB2200144 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-09-19 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
| JXHB2200145 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-09-19 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
| JXHB2200146 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-09-19 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
| JXHB2300058 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2023-04-04 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
| JXHB2300059 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2023-04-04 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
| JXHB2300060 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2023-04-04 | | Excella GmbH;Actelion Pharmaceuticals Ltd | | | view |
